Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Autologous Platelet Rich Plasma (PRP) intra ovarian infusion

Preclinical

GGenesis Athens Clinic

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Infertility, FemaleRecruiting

Infertility, FemalePreclinical

Recruiting

Timeline

Expected Milestones

Q3 2028

PreclinicalRecruiting

Infertility, Female

NCT03951194

Clinical

Trials by Indication[1]

Infertility, Female1 trial

Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Perimenopausal Women

Recruiting·GGenesis Athens Clinic·Preclinical·NCT03951194·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Autologous Platelet Rich Plasma (PRP) intra ovarian infusion. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Autologous Platelet Rich Plasma (PRP) intra ovarian infusion. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Genesis Athens Clinic company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: GGenesis Athens Clinic

Related News